Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis

Table 1 Summary of patient baseline characteristics

	Overall cohort (n = 42)	TOMOX (n = 18)	FOLFOX (n = 24)	P value
Gender				0.700
Male	29	13	16
Female	13	5	8
Age at first TACE (yr)	59 ± 10.7	60 ± 9.1	58 ± 11.8	0.473
Primary tumor site				0.601
Right hemicolon	10	5	5
Left hemicolon	32	19	13
Time to liver metastasis				0.508
Synchronous	28	11	17
Metachronous	14	7	7
Primary tumor grade				0.639
Poor	6	3	3
Well to moderate	36	15	21
Genetic condition				0.459
KRAS mutation	8	5	3
KRAS wild type	21	8	13
Unknown	13	5	8
Extrahepatic metastasis				0.927
Present	27	12	15
Absent	15	6	9
Combined with other local treatments				0.209
Yes	10	6	4
No	32	12	20